Published date: 7 July 2017
This notice was replaced on 5 November 2018
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 5 November 2018)
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Antivirals for systemic use - 33651400
Location of contract
Any region, Scotland, Wales, Northern Ireland, Isle of Man, Channel Islands
Value of contract
£0
Procurement reference
CM/EMI/16/5505
Published date
7 July 2017
Closing date
7 August 2017
Contract start date
16 April 2018
Contract end date
15 March 2022
Contract type
Supply contract
Procedure type
Restricted procedure
A two-stage procedure, where the first stage is used to select suppliers, who are then invited to bid in the second stage.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
This procurement exercise may result in one or more contracts for the provision of antivirals for use in an influenza pandemic, or a wide scale epidemic. The Authority will use any resulting contracts to maintain astockpile of products in the range of 23-38m treatment courses across all 4 lots.
The period of the contract is for four years with up to three 12 month extension options. The contract start/end date within this notice is a guide only.
More information
Attachments
-
- PDF published OJEU_PQQ_SQ docs.zip
- Contract notice
- OJEU and PQQ docs including SQ
Share this notice
All content is available under the
